U.S. Bioscience Inc. Announces European Introduction of Ethyol(R)

U.S. Bioscience Inc. has announced the first introduction for sale of Ethyol(R), a selective cytoprotective agent, in Germany, with plans to launch in the United Kingdom soon. This move follows the European Union's Committee for Proprietary Medicinal Products' recommendation for approval in September 1994, and the subsequent clearance for marketing in Germany, as well as other European countries. Ethyol is indicated for the reduction of neutropenia-related infection resulting from the use of the combination regimen cyclophosphamide and cisplatin in patients with advanced ovarian carcinoma. Schering-Plough introduced Ethyol in Germany on April 15 and has exclusive marketing rights in the European Union and European Free Trade Association countries.

Key Takeaways:

• Ethyol, a selective cytoprotective agent, was introduced for sale in Germany on April 15, 1995.
• The product is also approved for marketing in the United Kingdom, France, Spain, and Luxembourg.
• Schering-Plough has exclusive marketing rights to Ethyol in the European Union and European Free Trade Association countries.
• U.S. Bioscience Inc. has commercialization rights for products targeting patients with cancer and AIDS.
• Ethyol is indicated for reducing neutropenia-related infection in patients with advanced ovarian carcinoma.
• The European Union's Committee for Proprietary Medicinal Products recommended approval for Ethyol in September 1994.
• U.S. Bioscience Inc. is headquartered in West Conshohocken, Pennsylvania.
• Schering-Plough plans to launch Ethyol in other approved European markets upon gaining local pricing and reimbursement approvals.

Statistics:

• April 15, 1995: The date of Ethyol's introduction in Germany.
• April 17, 1995: The date of the U.S. Bioscience Inc. announcement of Ethyol's European introduction.
• 1994: The year the European Union's Committee for Proprietary Medicinal Products recommended approval for Ethyol.
• September 1994: The month and year of the European Union's Committee for Proprietary Medicinal Products' recommendation for approval.
• 5 countries: The number of European countries where Ethyol has been cleared for marketing, including the UK, France, Spain, and Luxembourg in addition to Germany.

Sources:

• BUSINESS WIRE - April 17, 1995
• U.S. BIOSCIENCE INC. press release, contact Robert I. Kriebel at 610/832-0570